Cackalacky2.0
Specimen
- Messages
- 9,023
- Reaction score
- 8,018
I suppose, but if they are testing a version that is the same as all of the current generics, not sure why anyone would pay for a more expensive version that has been repanteted. Bottom line is I've never read any articles with anyone theorizing that Ivermectin is a potential money grab. Now the 3.2 billion that the Feds are ready to throw out there, that's a different story.
This says there are 13 current patents related to invermectin. None of them are expired. Earliest expires in 2024.
As to paying more for a drug already in the market I guess insulin and epipen users didnt get that memo.